Quantcast
Last updated on April 18, 2014 at 7:21 EDT

Latest Verinata Health Inc. Stories

2013-02-15 20:21:19

REDWOOD CITY, Calif., Feb. 15, 2013 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today presented data demonstrating its approach to detect aneuploidies in maternal blood from multiple gestation pregnancies. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) Contrary to previous study findings by other investigators, this study demonstrated that each fetus in twin pregnancies contributes approximately 50 percent less...

2013-01-10 12:23:19

REDWOOD CITY, Calif., Jan. 10, 2013 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that its proprietary prenatal technology can detect fetal subchromosomal abnormalities non-invasively from maternal blood. These proof-of-concept data show that Verinata's proprietary approach together with deep massively parallel sequencing (MPS) is able to produce a non-invasive fetal karyotype equivalent to that provided by invasive...

2012-11-09 08:28:06

REDWOOD CITY, Calif., Nov. 9, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced two poster presentations at the 62(nd) Annual Meeting of the American Society of Human Genetics (ASHG). The conference is being held in San Francisco, California. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) "The verifi® prenatal test offers pregnant women access to a blood test that is safe, early and accurate,"...

2012-11-06 08:28:21

REDWOOD CITY, Calif., Nov. 6, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that it is expanding the verifi® prenatal test capabilities to include detection of the most common sex chromosome abnormalities. Clinicians will now be able to select the sex chromosomes option on the verifi® test to access this addition. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) Beginning December 3, 2012,...

2012-10-25 11:26:06

REDWOOD CITY, Calif., Oct. 25, 2012 /PRNewswire/ --Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that it has commenced an action against Ariosa Diagnostics, Inc. (Ariosa) and Laboratory Corporation of America Holdings (LabCorp) in federal court in the Northern District of California. The action asserts that Ariosa and LabCorp infringe U. S. Patent No. 8,296,076 (the '076 patent) entitled "Noninvasive Diagnosis of Fetal...

2012-10-24 07:31:19

REDWOOD CITY, Calif., Oct. 24, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that its verifi® prenatal test will be featured in several oral and poster presentations at the National Society of Genetic Counselors (NSGC) 31(st) Annual Education Conference. The conference is being held in Boston, Massachusetts from October 24 to 27, 2012. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) "Each of...

2012-10-03 02:27:43

REDWOOD CITY, Calif., Oct. 3, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced the addition of three industry veterans to its senior leadership team. Dr. Vance Vanier joins Verinata as President, Dr. Keith Jones as Senior Vice President of Research and Development and Dr. Suchetta Bhatt as Vice President of Genetics. (Logo: http://photos.prnewswire.com/prnh/20120425/SF94380LOGO) "As we expand our...

2012-07-02 02:23:58

REDWOOD CITY, Calif., July 2, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that its non-invasive verifi(TM) prenatal test can now be used to detect Turner syndrome (monosomy X or XO), a genetic condition in which a person has one X chromosome and is missing a second sex chromosome. Turner syndrome affects approximately one in every 2,000 female births. (Logo:...

2012-05-31 02:26:09

REDWOOD CITY, Calif., May 31, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that physicians across the country are now using the verifi(TM) prenatal test. In addition, the company will be presenting two key studies demonstrating the company's proprietary method to detect chromosomal abnormalities across the entire genome at the 16th International Conference on Prenatal Diagnosis and Therapy...

2012-04-25 02:32:23

REDWOOD CITY, Calif., April 25, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced the peer-reviewed publication of a new health economic model for its verifi(TM) prenatal test that clearly demonstrates the clinical and economic value of integrating the verifi(TM) prenatal test into current prenatal screening algorithms. The model shows a dramatic reduction in both the number and cost of invasive...